Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

healthcare-policy

A collection of 41 Posts

Trump Administration Secures Pfizer Drug Price Reduction Deal; WHO Advances Pandemic Agreement post image

Trump Administration Secures Pfizer Drug Price Reduction Deal; WHO Advances Pandemic Agreement

Trump Administration Escalates Pressure on Drugmakers with Tariff Threats Over Pricing and Domestic Manufacturing post image

Trump Administration Escalates Pressure on Drugmakers with Tariff Threats Over Pricing and Domestic Manufacturing

Pfizer Agreement Eases Pharma Tariff Fears, Sets Precedent for Drug Pricing Negotiations post image

Pfizer Agreement Eases Pharma Tariff Fears, Sets Precedent for Drug Pricing Negotiations

India's Pharma & Biotech Exports Target $30B Amidst New Government Innovation Partnership post image

India's Pharma & Biotech Exports Target $30B Amidst New Government Innovation Partnership

Trump Announces 100% Tariff on Branded Pharma Imports, Pressuring Global Supply Chains and Driving US Manufacturing post image

Trump Announces 100% Tariff on Branded Pharma Imports, Pressuring Global Supply Chains and Driving US Manufacturing

US Imposes 100% Tariff on Branded Pharma Imports, Aiming to Reshape Domestic Manufacturing post image

US Imposes 100% Tariff on Branded Pharma Imports, Aiming to Reshape Domestic Manufacturing

US to Impose 100% Tariff on Patented Pharma Imports, Signaling Major Supply Chain Shift post image

US to Impose 100% Tariff on Patented Pharma Imports, Signaling Major Supply Chain Shift

Analysis: Trump's 100% Pharmaceutical Tariff Triggers $270 Billion Investment Surge and Industry Reshoring post image

Analysis: Trump's 100% Pharmaceutical Tariff Triggers $270 Billion Investment Surge and Industry Reshoring

US Tariffs on Branded Drugs Spark Significant Decline in Indian Pharma Stocks post image

US Tariffs on Branded Drugs Spark Significant Decline in Indian Pharma Stocks

Analysis: Trump's Proposed 100% Pharma Tariff and Its Impact on Global Supply Chains and US Drug Costs post image

Analysis: Trump's Proposed 100% Pharma Tariff and Its Impact on Global Supply Chains and US Drug Costs

Proposed US Tariff on Branded Pharma: Experts Assess Limited Immediate Impact on Indian Generic Exports post image

Proposed US Tariff on Branded Pharma: Experts Assess Limited Immediate Impact on Indian Generic Exports

Healthcare Market Drivers: Peter Cardillo on Pharmaceutical Tariffs, AI, and Inflation's Impact post image

Healthcare Market Drivers: Peter Cardillo on Pharmaceutical Tariffs, AI, and Inflation's Impact